Trials / Conditions / Disitamab Vedotin
Disitamab Vedotin
3 registered clinical trials studyying Disitamab Vedotin — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Disitamab Vedotin Plus Lenvatinib and PD-1 Inhibitors for Treating HER2-positive Advanced Biliary Tract Cancer NCT07159217 | Peking Union Medical College Hospital | Phase 2 |
| Not Yet Recruiting | RC48 Combined With EGFR or HER2 TKI for Locally Advanced or Metastatic NSCLC Patients With HER2 Alterations NCT06185400 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 2 |
| Unknown | Disitamab Vedotin Combined Therapy for Locally Advanced or Metastatic NSCLC Patients With HER2 Alterations NCT05847764 | Sun Yat-sen University | Phase 2 |